| Deoxynucleoside therapy for thymidine kinase 2–deficient myopathy C Domínguez‐González, M Madruga‐Garrido, F Mavillard, C Garone, ... Annals of neurology 86 (2), 293-303, 2019 | 103 | 2019 |
| Profile of prescribing errors detected by clinical pharmacists in paediatric hospitals in Spain CM Fernández-Llamazares, M Pozas, B Feal, MJ Cabañas, M Villaronga, ... International journal of clinical pharmacy 35, 638-646, 2013 | 63 | 2013 |
| Oral nadolol for children with infantile hemangiomas and sleep disturbances with oral propranolol J Bernabeu‐Wittel, B Narváez‐Moreno, JM de la Torre‐García, ... Pediatric Dermatology 32 (6), 853-857, 2015 | 43 | 2015 |
| Two-round Delphi technique for the consensual design of a paediatric pharmaceutical care model CM Fernández-Llamazares, Y Hernández-Gago, M Pozas, MJ Cabañas, ... Pharmacological Research 68 (1), 31-37, 2013 | 35 | 2013 |
| Iatrogenic calcinosis cutis successfully treated with topical sodium thiosulfate E García‐García, R López‐López, C Álvarez‐del‐Vayo, ... Pediatric Dermatology 34 (3), 356-358, 2017 | 34 | 2017 |
| Gene signatures of early response to anti-TNF drugs in pediatric inflammatory bowel disease S Salvador-Martín, I Raposo-Gutiérrez, VM Navas-López, ... International journal of molecular sciences 21 (9), 3364, 2020 | 25 | 2020 |
| Lista modelo de medicamentos de alto riesgo JC Luque, MDG Aznar, CA del Vayo Benito, EJ Mesa, KPG Laura, ... Anales de Pediatría 79 (6), 360-366, 2013 | 23 | 2013 |
| Whole transcription profile of responders to anti-TNF drugs in pediatric inflammatory bowel disease S Salvador-Martín, B Kaczmarczyk, R Álvarez, VM Navas-López, ... Pharmaceutics 13 (1), 77, 2021 | 19 | 2021 |
| Formulación en farmacia pediátrica MA Fernández, JM Atienza, CÁ del Vayo A. Madrid Vicente Ediciones, 2011 | 17 | 2011 |
| Genetic predictors of long-term response to antitumor necrosis factor agents in pediatric inflammatory bowel disease S Salvador-Martín, F Bossacoma, G Pujol-Muncunill, VM Navas-López, ... Journal of pediatric gastroenterology and nutrition 71 (4), 508-515, 2020 | 16 | 2020 |
| Pharmacogenetics of trough serum anti‐TNF levels in paediatric inflammatory bowel disease S Salvador‐Martín, G Pujol‐Muncunill, F Bossacoma, VM Navas‐López, ... British Journal of Clinical Pharmacology 87 (2), 447-457, 2021 | 15 | 2021 |
| Revisión de la aplicación clínica de los colorantes en cromoendoscopia digestiva y su formulación magistral R Marín, MV Gil, MM Castellano, C Álvarez, O Belda Farmacia Hospitalaria 30 (2), 112-119, 2006 | 14 | 2006 |
| Lacosamide intake during pregnancy increases the incidence of foetal malformations and symptoms associated with schizophrenia in the offspring of mice B López-Escobar, R Fernández-Torres, V Vargas-López, M Villar-Navarro, ... Scientific Reports 10 (1), 7615, 2020 | 13 | 2020 |
| Nadolol for the treatment of infantile hemangioma AM Villalba-Moreno, J Cotrina-Luque, CA Del Vayo-Benito, ... American Journal of Health-System Pharmacy 72 (1), 44-46, 2015 | 11 | 2015 |
| Antimicrobial defined daily dose in neonatal population C Villanueva-Bueno, E Montecatine-Alonso, F Jiménez-Parrilla, ... Enfermedades infecciosas y microbiologia clinica (English ed.) 40 (2), 59-65, 2022 | 10 | 2022 |
| Medication errors in children visiting pediatric emergency departments GC Beatriz, OM José, JL Inés, HG Yolanda, TS Javier Farmacia Hospitalaria 47 (4), 141-147, 2023 | 8 | 2023 |
| Simplified human immunodeficiency virus maintenance therapy in virologically suppressed children with Ritonavir-boosted protease inhibitor monotherapy O Neth, L Falcon-Neyra, R Ruiz-Valderas, JAL Leal, I Obando, ... The Pediatric infectious disease journal 30 (10), 917, 2011 | 7 | 2011 |
| Álvarez del Vayo-Benito C, Flores-Moreno S, Bernabeu-Wittel J. Calcinosis cutánea grave tratada exitosamente con una fórmula magistral tópica W/O de tiosulfato sódico al 10% MA Pérez-Moreno Acta Pediatr Esp 72, e9-e10, 2014 | 5 | 2014 |
| Topical diltiazem for ulceration of striae distensae associated with bevacizumab therapy. RC Fuentes, JB Wittel, JC Mir, PS Paez, CA Vayo Dermatologic Therapy 32 (1), 2019 | 4 | 2019 |
| A model list of high risk drugs JC Luque, MDG Aznar, CA del Vayo Benito, EJ Mesa, KPG Laura, ... Anales de pediatria (Barcelona, Spain: 2003) 79 (6), 360-366, 2013 | 4 | 2013 |
